Cite
MLA Citation
C. Hurabielle et al.. “Efficacy and tolerance of ruxolitinib in refractory sclerodermatous chronic graft‐versus‐host disease.” British journal of dermatology, vol. 177, 2017, pp. e206–e208. http://access.bl.uk/ark:/81055/vdc_100172216589.0x000042